Skip to main content

Day: June 4, 2021

Ultimovacs ASCO Phase I data shows 60% ORR in advanced melanoma with UV1/pembrolizumab, supporting broad Phase II combination program

UV1/pembrolizumab results in 30% complete responses plus 30% partial responses Good safety and tolerability profile supports expanded Phase II combination program Data highlighted at ASCO in poster presentation Oslo, 4 June 2021: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, announced that data on its universal cancer vaccine, UV1, in combination with the checkpoint inhibitor pembrolizumab will be presented as a poster presentation at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting and available today at 9:00 am ET / 15:00 CEST. In a twenty patient cohort of patients with advanced melanoma, the combination of UV1 with pembrolizumab as a first-line treatment demonstrated an objective response rate (ORR) of 60% after a minimum of 18 months....

Continue reading

Heat Biologics to Showcase Favorable Survival Data of HS-110 in Previously Treated Non-Small Cell Lung Cancer Patients at 2021 American Society of Clinical Oncology Annual Meeting

Survival benefit observed in two treatment settings of previously treated non-small lung cancer patients DURHAM, N.C., June 04, 2021 (GLOBE NEWSWIRE) — Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced that Dr. Roger B. Cohen, MD, Professor of Medicine at the University of Pennsylvania Perelman School of Medicine, presented an overview of the latest HS-110 data at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting which is being held from June 4-8, 2021. This poster presentation can be viewed on Heat Biologics’ website at: https://www.heatbio.com/product-pipeline/scientific-publications. The ASCO Annual Meeting is the world’s largest oncology conference showcasing the latest advancements...

Continue reading

Paying Panostaja Oyj Board Members’ Fees in the Form of Shares Held by the Company

Panostaja Oyj       Stock Exchange Bulletin, Changes in Company´s own shares    4th June 2021, 16.00 p.m. Paying Panostaja Oyj Board Members’ Fees in the Form of Shares Held by the CompanyWith reference to Board meeting fees, Panostaja Oyj’s AGM decided on 5th February 2021 that about 40% of the fee paid to a board member should be paid in accordance with the share issue authorisation given to the Board by transferring company shares to each Board member unless a Board member should already own more than one per cent of the total share capital on the date of the AGM. If a Board member’s holding in the company on the date of the AGM should exceed one per cent of the total share capital, the fee shall be paid fully in cash. Panostaja Oyj’s Board also decided at its organisational meeting held upon completion of the AGM to implement the...

Continue reading

Genocea Presents Promising Long-term Results from GEN-009 Neoantigen Vaccine Phase 1 Trial at ASCO 2021

Four of nine checkpoint inhibitor-sensitive patients experienced RECIST responses post vaccination; median duration without disease progression after initial GEN-009 vaccination was 15 months Two of seven CPI-refractory patients experienced stable disease for up to 10 months after initial GEN-009 vaccination In the monotherapy cohort, six of eight patients with no measurable disease continue without recurrence for a median duration of 25 months after initial GEN-009 vaccination Augmented T cell responses to ATLAS™-identified vaccine neoantigens were durable for at least 6 months post first GEN-009 vaccination CAMBRIDGE, Mass., June 04, 2021 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, presents updated immunogenicity and clinical response...

Continue reading

Leaf Group Receives Letter from Graham Holdings

Graham Holdings Makes Clear It Will Not Raise Merger Consideration of $8.50 Per Share SANTA MONICA, Calif., June 04, 2021 (GLOBE NEWSWIRE) — Leaf Group Ltd. (“Leaf Group” or the “Company”) (NYSE: LEAF), a diversified consumer internet company, today announced that it received the following letter from Graham Holdings Company (“Graham Holdings”) (NYSE: GHC) regarding its pending acquisition of the Company: Arlington, Virginia June 3, 2021 Leaf Group Ltd. (“Leaf Group” or the “Company”)1655 26th StreetSanta Monica, CA 90404Attention: Mr. Sean Moriarty, Chief Executive Officer with copies to: the Board of Directors of Leaf Group Ltd. Dear Sean, We are writing to provide clarity to you and to the Leaf Group stockholders, and reiterate that we will not increase the merger consideration of $8.50 in cash per share of Leaf Group common...

Continue reading

ABO-Group Environment lists on Euronext Paris

Ghent, 4th of June 2021, 15:00 – Press release / Regulated Information  Euronext today congratulates ABO-Group Environment, an engineering company in the environment sector which operates in the activities of geotechnics, soil remediation, energy and water and waste management, on the Compartment C of Euronext’s regulated market in Paris (ticker code: ABO).  ABO helps organisations and local authorities in Belgium, in the Netherlands and in France, face the major challenges of our era, such as risks linked to climate change or the pollution of our soils through multiple origins. After listing on Euronext Brussels in 2014, the listing on Euronext Paris was a natural next step for ABO-Group Environment since the group now derives more than 50% of its revenues from France, following three recent acquisitions. The group’s aim with this dual...

Continue reading

Beyond Meat® Announces New Executive Leadership Appointments to Accelerate and Support the Company’s Vision for Strategic Growth

Phil Hardin Joins as Chief Financial Officer Deanna Jurgens Joins as Chief Growth Officer Margaret “Jackie” Trask Joins as Chief People Officer EL SEGUNDO, Calif., June 04, 2021 (GLOBE NEWSWIRE) — Beyond Meat, Inc. (NASDAQ: BYND), a leader in plant-based meat, today announced the appointments of Phil Hardin as Chief Financial Officer, Deanna Jurgens as Chief Growth Officer and Margaret “Jackie” Trask as Chief People Officer. These seasoned veterans bring extensive experience to the Beyond Meat executive leadership team to support the company’s continued growth and innovation-focused culture. “We are excited to welcome Phil, Deanna and Jackie to the Beyond Meat executive leadership team,” said Ethan Brown, President and Chief Executive Officer, Beyond Meat. “In each case, we conducted extensive searches to identify best-in-class...

Continue reading

Gold X Announces Completion of Plan of Arrangement with Gran Colombia Gold Corp.

VANCOUVER, British Columbia, June 04, 2021 (GLOBE NEWSWIRE) — Gold X Mining Corp. (TSXV: GLDX) (“Gold X“) is pleased to announce the completion of the previously announced plan of arrangement (the “Arrangement“) under the Business Corporations Act (British Columbia) pursuant to which Gran Colombia Gold Corp. (“Gran Colombia“) has acquired all of the issued and outstanding common shares of Gold X (the “Gold X Shares“) not previously owned by Gran Colombia in exchange for Gran Colombia common shares (“Gran Colombia Shares“) on the basis of 0.6948 of a Gran Colombia Share for each Gold X Share. As a result of the Arrangement, Gold X has become a wholly-owned subsidiary of Gran Colombia and the Gold X Shares are anticipated to be de-listed from the TSX Venture Exchange on...

Continue reading

omniQ Signs Agreement with Multibillion Dollar Medical Center for its AI Based Cloud Software for Campus Parking Management, PERCS™

ominQ to deploy PERCS™️ (Permitting, Enforcement, Revenue and Collection) Cloud-hosted Software PERCS™ represents a SaaS Revenue model Additional Gold Service Level Agreement (SLA) provides 24/7/365 support coverageSALT LAKE CITY, June 04, 2021 (GLOBE NEWSWIRE) — omniQ Corp (OTCQB: OMQS) (“OMNIQ” or “the Company”), a provider of Artificial Intelligence (AI) and IoT – based solutions, announced today a Phase 1 Software as a Service Agreement with a multi-billion dollar top ranked medical center (Medical Center), to deploy its PERCS™ (Permitting, Enforcement, Revenue and Collection) Cloud-hosted Software for campus parking management.   On an annual basis, the Medical Center generates more than $5 billion in revenue, seeing more than 5 million patients, with more than 50,000 employees and runs a campus on more than 100 acres...

Continue reading

CSX Announces Stock Split

JACKSONVILLE, Fla., June 04, 2021 (GLOBE NEWSWIRE) — CSX Corporation (NASDAQ: CSX) today announced that its Board of Directors has approved a 3-for-1 stock split to be distributed to shareholders as a stock dividend.   Each shareholder of record at the close of business on June 18, 2021, will receive two additional shares of CSX common stock for each share held as of this record date. The new shares will be distributed on June 28, 2021. The regular, quarterly cash dividend of $0.28 per share payable on June 15, 2021, will not be impacted by the stock split.   Based on the current dividend rate, the post-split quarterly dividend on the company’s common stock would be $0.093* per share. *On a post-split basis, the dividend will be carried out six decimal places to most closely approximate the current dividend amount. About...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.